InCadence Strategic Solutions in Liberia to Support Fight Against Ebola
Biometric Enrollment and Tracking Solution Used to Maintain Integrity of Vaccine Trials
Monrovia, Liberia, April 3, 2017 – InCadence Vice President of Data Solutions, David Boyd was in attendance today as the Partnership for Research on Ebola Virus in Liberia (PREVAIL) launched the expansion of the Ebola vaccine study during a packed event at Redemption Hospital, in New Kru Town, Monrovia, Liberia. The study will assess three different test vaccine strategies in an effort to find which show the most promise to prevent or quickly control future Ebola outbreaks.
David Boyd of InCadence at vaccination site at Redemption Hospital in Liberia.
To help maintain the integrity of the Ebola vaccine studies and assure that the correct participants are tracked through the study protocols, InCadence Strategic Solutions Corp. under contract with Leidos Biomed, has developed the AIRMED biometric enrollment and tracking solution. AIRMED is a light weight portable biometric enrollment, verification, and participant scheduling solution designed to operate in remote locations with limited communications and network connectivity. InCadence deployed AIRMED in November 2016 and trained clinical staff at Redemption Hospital in preparation for the current PREVAIL V series of vaccine trials.
A vaccine study participant enrolls using the AIRMED biometric solution.
“Biometric verification of participant identities is critical to maintaining the integrity of the study and associated data,” said David Boyd, Vice President of Data Solutions at InCadence.
“Because participants are compensated for their time under the study, there are incentives for people to fraudulently present themselves as study participants. This kind of fraud not only degrades the quality of the data collected under the study but also creates risks for study participants and those fraudulently participating,” further noted Mr. Boyd.”
In addition to its work with AIRMED, InCadence is also supporting PREVAIL with media monitoring and sentiment analysis related to government response, social mobilization, survivor stigma, and other issues associated with the Ebola outbreak and the clinical trials.
In attendance during today’s event:
In attendance were dignitaries including Liberia’s Vice President, Amb. Joseph Nyumah Boakai, Dr. Emily Kainne Dokubo, Deputy Director for Programs at the US Centers for Disease Control and Prevention in Liberia (representing the US Ambassador to Liberia Christine Elder), John Tierney of the NIH, the Director-General of the National Public Health Institute, Tolbert Nyenswah, Senate Committee Chair on Health and Gender, Dr. Peter Coleman and the head of Liberia’s Traditional Council of Chiefs and Elder, Chief Zanzan Karwor. Also on hand were staff of NIH, LEIDOS, PREVAIL, TMG, as well as Community and religious leaders, and David Boyd of InCadence. The West Africa Regional Consortium was represented by its chairman, Dr. Moses Massaquoi.
About InCadence Strategic Solutions Corp.
InCadence Strategic Solutions Corp., founded in 2009, is an award-winning Women-Owned Small Business (WOSB) headquartered in Northern Virginia. InCadence specializes in providing cutting-edge technical solutions for our government and commercial clients in the following areas: Biometrics and Identity Management, Operational Intelligence, Information Management and Tactical Communications.
InCadence is an Equal Opportunity Employer, M/F/PV/D.
For more information about InCadence Strategic Solutions Corp. visit incadencecorp.com.